James, C. et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull. World Health Organ. 98, 315–329 (2020).
Heldwein, E. E. & Krummenacher, C. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 65, 1653–1668 (2008).
Cooper, R. S., Georgieva, E. R., Borbat, P. P., Freed, J. H. & Heldwein, E. E. Structural basis for membrane anchoring and fusion regulation of the herpes simplex virus fusogen gB. Nat. Struct. Mol. Biol. 25, 416–424 (2018).
Liu, Y. et al. Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion. Sci. Adv. 7, eabf3178 (2021).
Hsieh, C. L. et al. Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge. Nat. Commun. 15, 1553 (2024).
Crank, M. C. et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science 365, 505–509 (2019).
Hsieh, C. L. et al. Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins. Nat. Commun. 13, 1299 (2022).
Rutten, L. et al. Structure-based design of prefusion-stabilized filovirus glycoprotein trimers. Cell Rep. 30, 4540–4550 (2020).
Hsieh, C. L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501–1505 (2020).
Loomis, R. J. et al. Structure-based design of nipah virus vaccines: a generalizable approach to paramyxovirus immunogen development. Front. Immunol. 11, 842 (2020).
Pallesen, J. et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl Acad. Sci. USA 114, E7348–E7357 (2017).
Krarup, A. et al. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat. Commun. 6, 8143 (2015).
Rutten, L. et al. A universal approach to optimize the folding and stability of prefusion-closed HIV-1 envelope trimers. Cell Rep. 23, 584–595 (2018).
Sanders, R. W. et al. HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349, aac4223 (2015).
Bowen, J. E. et al. SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Sci. Immunol. 7, eadf1421 (2022).
Vollmer, B. et al. The prefusion structure of herpes simplex virus glycoprotein B. Sci. Adv. 6, eabc1726 (2020).
Sponholtz, M. R. et al. Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation. Proc. Natl Acad. Sci. USA 121, e2404250121 (2024).
Si, Z. et al. Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate. PLoS Pathog. 14, e1007452 (2018).
Chi, X. S., Dormitzer, P. R., Liu, W. & Liu, Y. Novel druggable regions in the human cytomegalovirus glycoprotein B polypeptide and methods of use thereof. US patent 20240299587A1 (2022).
Bender, F. C. et al. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions. J. Virol. 81, 3827–3841 (2007).
Cairns, T. M. et al. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B. J. Virol. 88, 2677–2689 (2014).
Zhong, L. et al. Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents. Trends Microbiol. 31, 788–804 (2023).
Pereira, L., Ali, M., Kousoulas, K., Huo, B. & Banks, T. Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology 172, 11–24 (1989).
Guttler, T. et al. Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies. EMBO J. 40, e107985 (2021).
Huo, J. et al. A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat. Commun. 12, 5469 (2021).
Zeev-Ben-Mordehai, T., Vasishtan, D., Siebert, C. A., Whittle, C. & Grunewald, K. Extracellular vesicles: a platform for the structure determination of membrane proteins by Cryo-EM. Structure 22, 1687–1692 (2014).
Zeev-Ben-Mordehai, T. et al. Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B. Proc. Natl Acad. Sci. USA 113, 4176–4181 (2016).
Frey, S. & Gorlich, D. A new set of highly efficient, tag-cleaving proteases for purifying recombinant proteins. J. Chromatogr. A 1337, 95–105 (2014).
Ebel, H., Benecke, T. & Vollmer, B. Stabilisation of viral membrane fusion proteins in prefusion conformation by structure-based design for structure determination and vaccine development. Viruses 14, 1816 (2022).
Vallbracht, M. et al. In vitro viral evolution identifies a critical residue in the alphaherpesvirus fusion glycoprotein B ectodomain that controls gH/gL-independent entry. mBio 12, e00557-21 (2021).
Elegheert, J. et al. Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins. Nat. Protoc. 13, 2991–3017 (2018).
Carlson, M. L. et al. The Peptidisc, a simple method for stabilizing membrane proteins in detergent-free solution. eLife 7, e34085 (2018).
Heldwein, E. E. et al. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313, 217–220 (2006).
Stampfer, S. D., Lou, H. A., Cohen, G. H., Eisenberg, R. J. & Heldwein, E. E. Structural basis of local, pH-dependent conformational changes in glycoprotein B from herpes simplex virus type 1. J. Virol. 84, 12924–12933 (2010).
Oliver, S. L. et al. A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation. Nat. Commun. 11, 4141 (2020).
Burke, H. G. & Heldwein, E. E. Crystal structure of the human cytomegalovirus glycoprotein B. PLoS Pathog. 11, 21 (2015).
Backovic, M., Longnecker, R. & Jardetzky, T. S. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc. Natl Acad. Sci. USA 106, 2880–2885 (2009).
Serris, A. et al. The hantavirus surface glycoprotein lattice and its fusion control mechanism. Cell 183, 442–456 (2020).
Hannah, B. P. et al. Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops. J. Virol. 83, 6825–6836 (2009).
Pleiner, T. et al. Nanobodies: site-specific labeling for super-resolution imaging, rapid epitope-mapping and native protein complex isolation. eLife 4, e11349 (2015).
Satoh, T. et al. PILR alpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132, 935–944 (2008).
Fukui, A. et al. Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence. mBio 14, e0099223 (2023).
McCallum, M. & Veesler, D. Computational design of prefusion-stabilized Herpesvirus gB trimers. Preprint at bioRxiv https://doi.org/10.1101/2024.10.23.619923 (2024).
Hellert, J. et al. Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein. Nat. Commun. 11, 596 (2020).
Callaway, H. M. et al. Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Sci. Adv. 8, eabp9151 (2022).
Harris, L. J., Larson, S. B., Hasel, K. W. & McPherson, A. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36, 1581–1597 (1997).
Dai, X. & Zhou, Z. H. Structure of the herpes simplex virus 1 capsid with associated tegument protein complexes. Science 360, eaao7298 (2018).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Bolte, S. & Cordelieres, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213–232 (2006).
Mastronarde, D. N. SerialEM: a program for automated tilt series acquisition on Tecnai microscopes using prediction of specimen position. Microsc. Microanal. 9, 1182–1183 (2003).
Tegunov, D. & Cramer, P. Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146–1152 (2019).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Jamali, K. et al. Automated model building and protein identification in cryo-EM maps. Nature 628, 450–457 (2024).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. 66, 486–501 (2010).
Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D 74, 519–530 (2018).
Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. 66, 22–25 (2010).
Yamashita, K., Palmer, C. M., Burnley, T. & Murshudov, G. N. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr. D 77, 1282–1291 (2021).
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861–877 (2019).
Beton, J. G., Mulvaney, T., Cragnolini, T. & Topf, M. Cryo-EM structure and B-factor refinement with ensemble representation. Nat. Commun. 15, 444 (2024).
Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
Olek, M. & Joseph, A. P. Cryo-EM map-based model validation using the false discovery rate approach. Front. Mol. Biosci. 8, 652530 (2021).
Chojnowski, G. et al. findMySequence: a neural-network-based approach for identification of unknown proteins in X-ray crystallography and cryo-EM. IUCrJ 9, 86–97 (2022).
Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007).
Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).
Madeira, F. et al. The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024. Nucleic Acids Res. 52, W521–W525 (2024).
Valdar, W. S. & Thornton, J. M. Protein–protein interfaces: analysis of amino acid conservation in homodimers. Proteins 42, 108–124 (2001).
Valdar, W. S. Scoring residue conservation. Proteins 48, 227–241 (2002).
Cragnolini, T. et al. TEMPy2: a Python library with improved 3D electron microscopy density-fitting and validation workflows. Acta Crystallogr. D 77, 41–47 (2021).
Touw, W. G. et al. A series of PDB-related databanks for everyday needs. Nucleic Acids Res. 43, D364–D368 (2015).
Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).
Kartal, Ö., Andres, F., Lai, M. P., Nehme, R. & Cottier, K. waveRAPID—a robust assay for high-throughput kinetic screens with the Creoptix WAVEsystem. SLAS Discov. 26, 995–1003 (2021).
